The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.


The dopamine D4 receptor is a potential target for novel antipsychotic drugs. Most available compounds with affinity for the dopamine D4 receptor also bind to dopamine D2 receptors. This report describe the affinity of the 5-HT2A receptor antagonist RP 62203 (fananserin) for the human dopamine D4 receptor. Fananserin displaces [3H]spiperone binding to… (More)


  • Presentations referencing similar topics